Log in to save to my catalogue

Micafungin: A Review of its Use in Adults for the Treatment of Invasive and Oesophageal Candidiasis,...

Micafungin: A Review of its Use in Adults for the Treatment of Invasive and Oesophageal Candidiasis,...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20052754

Micafungin: A Review of its Use in Adults for the Treatment of Invasive and Oesophageal Candidiasis, and as Prophylaxis Against Candida Infections

About this item

Full title

Micafungin: A Review of its Use in Adults for the Treatment of Invasive and Oesophageal Candidiasis, and as Prophylaxis Against Candida Infections

Publisher

Cham: Springer International Publishing

Journal title

Drugs (New York, N.Y.), 2008-01, Vol.68 (15), p.2225-2255

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Summary
Intravenous micafungin (Mycamine®; Fungard®), an echinocandin, inhibits the synthesis of 1,3-β-
D
-glucan, an essential cell wall component in many fungi. It is approved in adults (focus of this review) and in neonates and paediatric patients
(Pediatric Drugs
[in press]) in the EU and elsewhere for the treatment of invasive c...

Alternative Titles

Full title

Micafungin: A Review of its Use in Adults for the Treatment of Invasive and Oesophageal Candidiasis, and as Prophylaxis Against Candida Infections

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_20052754

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20052754

Other Identifiers

ISSN

0012-6667

E-ISSN

1179-1950

DOI

10.2165/00003495-200868150-00010

How to access this item